Tags

Type your tag names separated by a space and hit enter

Immune checkpoint inhibitors in cancer treatment and potential effect modification by age.
Acta Oncol. 2020 Mar; 59(3):247-248.AO

Authors+Show Affiliations

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Pub Type(s)

Editorial

Language

eng

PubMed ID

32036733

Citation

Eriksson, Hanna, and Karin E. Smedby. "Immune Checkpoint Inhibitors in Cancer Treatment and Potential Effect Modification By Age." Acta Oncologica (Stockholm, Sweden), vol. 59, no. 3, 2020, pp. 247-248.
Eriksson H, Smedby KE. Immune checkpoint inhibitors in cancer treatment and potential effect modification by age. Acta Oncol. 2020;59(3):247-248.
Eriksson, H., & Smedby, K. E. (2020). Immune checkpoint inhibitors in cancer treatment and potential effect modification by age. Acta Oncologica (Stockholm, Sweden), 59(3), 247-248. https://doi.org/10.1080/0284186X.2020.1724329
Eriksson H, Smedby KE. Immune Checkpoint Inhibitors in Cancer Treatment and Potential Effect Modification By Age. Acta Oncol. 2020;59(3):247-248. PubMed PMID: 32036733.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immune checkpoint inhibitors in cancer treatment and potential effect modification by age. AU - Eriksson,Hanna, AU - Smedby,Karin E, Y1 - 2020/02/08/ PY - 2020/2/11/pubmed PY - 2020/11/24/medline PY - 2020/2/11/entrez SP - 247 EP - 248 JF - Acta oncologica (Stockholm, Sweden) JO - Acta Oncol VL - 59 IS - 3 SN - 1651-226X UR - https://www.unboundmedicine.com/medline/citation/32036733/Immune_checkpoint_inhibitors_in_cancer_treatment_and_potential_effect_modification_by_age_ DB - PRIME DP - Unbound Medicine ER -